CRL Charles River Laboratories International, Inc. Common Stock
$290.01
가격 · 8월 19, 2026
기준 재무 정보 8월 5, 2026
52주 범위
$144–$291
99% of range
애널리스트 평점
BUY
22 analysts
목표 주가
$281
P/E (TTM)
-99.7
ROE
-4.4%
순이익률
-3.6%
Charles River Laboratories International, Inc. Common Stock 정보 위키백과 회사 개요
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
더 보기
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration (FDA). The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.
History
Charles River was founded in 1947 by Henry Foster, a young veterinarian who purchased one thousand rat cages from a Virginia farm and set up a one-person laboratory in Boston overlooking the Charles River. He supplied local researchers with laboratory animals.
In 1955, the company's headquarters were relocated to their current home in Wilmington, Massachusetts. The organization became an international entity in 1966 by opening a new animal production facility in France.
The first commercial, comprehensive genetic monitoring program was implemented by Charles River in 1981. Three years later, they were acquired by Bausch & Lomb. In 1988, the organization began creating transgenic mice and rats. In the 1990s, they began in vitro endotoxin testing. In the 1990s, Jim Foster bought Charles River back from Bausch & Lomb, and the company later went public on the New York Stock Exchange.
Charles River launched the Humane Care Imperative in 2002, designed to raise awareness and train employees on animal welfare's importance. The same year, they were named "Company of the Year" by The Boston Globe. The company introduced preconditioning services in 2005 to provide customers with study-ready animals.
In 2008, Charles River signed a ten-year contract to partner with the National Cancer Institute and opened a facility in Frederick, Maryland.
In April 2019, Charles River announced it would cease its San Diego operations, moving the breeding of rodents for testing compounds to Hollister, California.
In March 2023, the Born Free USA animal welfare organization protested against Charles River's plan to export 1,000 endangered juvenile long-tail macaques to Cambodia for testing.
Acquisitions
In 1988, Charles River purchased Specific Pathogen Antigen Free Avian Services (SPAFAS) and serologic diagnostic services Merck, Sharp, and Dohme.
Between 1996 and 2000, the company acquired Endosafe, Inc. and Sierra Biomedical.
In October 2003, Charles River Laboratories merged with Inveresk, a research company based in the United Kingdom. The company was known then as Charles River Laboratories. Inveresk specialised in clinical research and pre-clinical testing, and their main facilities are in Edinburgh, Scotland. In late 2009, Charles River sold its Clinical Services Division in Edinburgh to Quotient Bioresearch.
In 2010, Charles River Laboratories attempted to acquire WuXi PharmaTech, a China-based contract research organization, but the offer was withdrawn when the deal faced opposition from several large Charles River investors, including Relational Investors, JANA Partners, and Neuberger Berman. The proxy advisory firm RiskMetrics had also recommended that Charles River's shareholders vote against the proposed deal.
From 2008 to 2013, Charles River acquires several companies including NewLab Bioquality AG, MIR Preclinical Services, Piedmont Research Center, LLC, Cerebricon, Ltd., Accugenix, and Vital River, allowing the company to expand their research models and services portfolio to drug development and discovery markets in China.
The acquisitions of Argenta and BioFocus in 2014 allowed Charles River to establish itself as a full-service, early-stage contract research organization with integrated in vitro and in vivo capabilities from target discovery through pre-clinical development.
In July 2015, the company announced it would acquire Celsis International for $212 million.
In 2016, the company announced it was set to acquire WIL Research for approximately $585 million in cash and Blue Stream Laboratories.
In August 2017, the business announced it would acquire Brains On-Line.
In January 2018, the company announced it would acquire KWS BioTest for up to £18 million ($24.4 million). In February of the same year, Charles River announced it would acquire MPI Research for approximately $800 million in cash. The transaction was completed on April 3, 2018.
In February 2019, the company announced it would acquire Citoxlab for €448 million in cash (approximately $500 million), including the former acquisitions of the French company, AccelLAB, Atlanbio and Solvo Biotechnology. The transaction was completed on April 29. In December of the same year the business announced it would acquire HemaCare for approximately $380 million in cash.
In August 2020, the company announced it would acquire Cellero for $38 million in cash.
In January 2021, the company announced it would acquire Distributed Bio, Inc., an antibody discovery business.
In February 2021, Charles River announced it would acquire Cognate BioServices, Inc. for $875 million.
In March 2021, Charles River announced the acquisition of Retrogenix for $48 million.
In May 2021, Charles River announced the acquisition of Vigene Biosciences, a gene therapy contract development and manufacturing organization (CDMO), for $292.5 million.
In October 2021, a Japanese subsidiary of Charles River was acquired by Jackson Laboratory for $63M USD.
In April 2022, the company announced it would acquire Explora BioLabs.
In January 2023, the business announced it would acquire SAMDI Tech, Inc.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
CRL 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$290.00
시가총액
$14.27B
P/E (TTM)
-99.7
EPS (TTM)
$-2.91
매출 (TTM)
$4.02B
배당 수익률
—
ROE
-4.4%
부채/자본
0.0
52주 범위
$144 – $291
CRL 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$4.02B
2016-12-31
→
2025-12-27
EPS
$-2.91
2016-12-31
→
2025-12-27
잉여현금흐름
$518M
2016-12-31
→
2025-12-27
마진
-3.6%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
CRL
동종업계 중앙값
P/E (TTM)
-99.7
39.9
P/S (TTM)
3.6
5.6
P/B
4.5
4.1
EV / EBITDA
32.8
—
Price / FCF (주가 / FCF)
27.5
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
CRL
동종업계 중앙값
Operating Margin (영업이익률)
0.63%
—
Net Profit Margin (순이익률)
-3.6%
11.7%
ROA
-2.0%
4.7%
ROE
-4.4%
8.5%
ROIC
1.1%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
CRL
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
0.0
15.3
Current Ratio (유동비율)
1.3
1.7
Quick Ratio (당좌 비율)
0.8
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
CRL
동종업계 중앙값
Revenue YoY (매출 YoY)
-0.85%
—
Revenue CAGR 3Y (매출 CAGR 3년)
0.33%
—
Revenue CAGR 5Y (매출 CAGR 5년)
6.6%
—
EPS YoY
-97.8%
—
Net Income YoY (순이익 YoY)
-95.3%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
CRL
동종업계 중앙값
CRL 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
22 명의 애널리스트
- 적극 매수 5 22.7%
- 매수 10 45.5%
- 보유 7 31.8%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
14 명의 애널리스트 · 2026-08-14
중앙값
$300.00
평균
$281.00
지금
$290.00
저가
$145.00
고가
$318.00
중앙값 목표
$300.00
+3.4%
평균 목표
$281.00
-3.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.21%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $3.02 | $2.76 | 0.26% |
| 2026년 3월 31일 | $2.06 | $1.96 | 0.10% |
| 2025년 12월 31일 | $2.39 | $2.37 | 0.02% |
| 2025년 9월 30일 | $2.43 | $2.36 | 0.07% |
| 2025년 6월 30일 | $3.12 | $2.52 | 0.60% |
| 2025년 3월 31일 | $2.34 | $2.10 | 0.24% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | — |
| TECH | $7.97B | 111.8 | 5.2% | 6.0% | 3.7% | 64.8% |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | — |
| BIO | — | — | — | — | — | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $290M | $277M | $264M | $266M | |
| SG&A Expense | $743M | $751M | $748M | $665M | $620M | $529M | $518M | $444M | $371M | $365M | $300M | $269M | |
| Operating Income | $25M | $227M | $617M | $651M | $590M | $433M | $351M | $331M | $288M | $238M | $206M | $178M | |
| Interest Expense | · | · | $137M | $59M | $74M | $86M | $61M | $64M | $30M | $28M | $15M | $12M | |
| Interest Income | $5M | $9M | $5M | $780.0K | $652.0K | $834.0K | $2M | $812.0K | $690.0K | $1M | $1M | $1M | |
| Other Non-op | $-23M | $-17M | $96M | $31M | $-36M | $100M | $12M | $13M | $38M | $12M | $3M | $11M | |
| Pretax Income | $-100M | $93M | $581M | $623M | $481M | $447M | $304M | $282M | $297M | $223M | $195M | $178M | |
| Income Tax | $43M | $68M | $101M | $130M | $82M | $82M | $50M | $54M | $171M | $67M | $43M | $48M | |
| Net Income | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| EPS (Basic) | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | |
| EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | |
| Shares (Basic) | 49,564,000 | 51,380,000 | 51,227,000 | 50,812,000 | 50,293,000 | 49,550,000 | 48,730,000 | 47,947,000 | 47,481,000 | 47,014,000 | 46,496,000 | 46,627,000 | |
| Shares (Diluted) | 49,564,000 | 51,628,000 | 51,451,000 | 51,301,000 | 51,425,000 | 50,611,000 | 49,693,000 | 49,018,000 | 48,564,000 | 47,958,000 | 47,634,000 | 47,558,000 | |
| EBITDA | $428M | $589M | $931M | $955M | $855M | $668M | $549M | $493M | $419M | $364M | $301M | $274M |
대차대조표 30
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $195M | $277M | $234M | $241M | $228M | $238M | $195M | $164M | $118M | $118M | $160M | |
| Short-term Investments | · | · | · | · | $1M | $1M | $941.0K | $885.0K | $28M | $4M | $21M | · | |
| Receivables | $709M | $721M | $780M | $752M | $643M | $618M | $514M | $472M | $430M | $364M | $270M | $258M | |
| Inventory | $299M | $279M | $380M | $256M | $199M | $186M | $161M | $128M | $115M | $96M | $94M | $89M | |
| Prepaid Expense | $129M | $106M | $83M | $108M | $97M | $73M | $56M | $49M | $81M | $45M | $47M | $45M | |
| Other Current Assets | · | · | · | · | · | $0 | $300.0K | $300.0K | $0 | $45M | $47M | $73M | |
| Current Assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B | $1.20B | $1.02B | $898M | $827M | $657M | $559M | $579M | |
| PP&E (Net) | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B | $1.12B | $1.04B | $933M | $782M | $756M | $678M | $677M | |
| PP&E (Gross) | $3.19B | $3.06B | $2.98B | $2.63B | $2.39B | $2.21B | $2.02B | $1.81B | $1.58B | $1.46B | $1.32B | $1.33B | |
| Accum. Depreciation | $1.54B | $1.45B | $1.34B | $1.16B | $1.10B | $1.09B | $978M | $874M | $801M | $706M | $645M | $655M | |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B | $1.81B | $1.54B | $1.25B | $805M | $788M | $439M | $321M | |
| Intangibles | $340M | $723M | $864M | $955M | $1.06B | $788M | $689M | $611M | $370M | $394M | $281M | $281M | |
| Other Non-current Assets | $293M | $278M | $309M | $148M | $152M | $353M | $213M | $144M | $124M | $88M | $72M | $73M | |
| Total Assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Accounts Payable | $149M | $140M | $169M | $206M | $198M | $122M | $111M | $66M | $78M | $68M | $37M | $34M | |
| Accrued Liabilities | $270M | $232M | $228M | $220M | $229M | $150M | $139M | $107M | $90M | $84M | $89M | $67M | |
| Current Liabilities | $1.12B | $994M | $1.06B | $1.09B | $1.03B | $840M | $710M | $558M | $464M | $430M | $312M | $295M | |
| Capital Leases | $434M | $484M | $419M | $390M | $253M | $156M | $116M | · | · | · | · | · | |
| Deferred Tax | $95M | $107M | $191M | $216M | $240M | $217M | $167M | $144M | $90M | $56M | $48M | $23M | |
| Other Non-current Liabilities | $138M | $195M | $223M | $175M | $243M | $205M | $183M | $179M | $195M | $159M | $89M | $100M | |
| Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B | $3.03B | $2.52B | $1.87B | $1.86B | $1.30B | $1.17B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.61B | $1.09B | $1.18B | $814M | $717M | |
| Total Debt | $166.0K | $155.0K | $3M | $1M | $101.0K | $47M | $36M | $1.65B | $1.12B | $1.21B | $836M | $754M | |
| Common Stock | $492.0K | $511.0K | $513.0K | $509.0K | $505.0K | $498.0K | $489.0K | $482.0K | $875.0K | $863.0K | $855.0K | $845.0K | |
| Retained Earnings | $1.39B | $1.81B | $1.89B | $1.43B | $981M | $625M | $280M | $42M | $289M | $165M | $11M | $-139M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $55.0K | $1.66B | $1.55B | $1.54B | $1.42B | |
| AOCI | $-172M | $-317M | $-196M | $-262M | $-165M | $-139M | $-178M | $-173M | $-145M | $-254M | $-136M | $-74M | |
| Stockholders' Equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B | $1.63B | $1.32B | $1.05B | $837M | $733M | $672M | |
| Liabilities + Equity | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B | $2.07B | $1.87B | |
| Shares Outstanding | 49,217,000 | 51,141,000 | 51,338,000 | 50,944,000 | 50,480,000 | 49,767,000 | 48,936,000 | 48,209,000 | 47,402,000 | 47,363,000 | 46,698,000 | 47,327,000 |
현금 흐름 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $403M | $362M | $314M | $304M | $266M | $235M | $198M | $162M | $131M | $127M | $95M | $96M | |
| Stock-based Comp | $71M | $70M | $72M | $74M | $71M | $56M | $57M | $47M | $44M | $44M | $40M | $31M | |
| Deferred Tax | $-75M | $-67M | $-51M | $-33M | $-20M | $2M | $-21M | $-10M | $28M | $3M | $4M | $9M | |
| Amort. of Intangibles | $179M | $138M | $137M | $147M | $125M | $112M | $90M | $65M | $41M | $42M | $24M | $26M | |
| Restructuring | $100M | $107M | $30M | $8M | $7M | $13M | $14M | $10M | $5M | $18M | $8M | $8M | |
| Other Non-cash | $483M | $348M | $-126M | $-211M | $53M | $-111M | $-5M | $16M | $-8M | $-28M | $-395.0K | · | |
| Operating Cash Flow | $738M | $735M | $684M | $620M | $761M | $547M | $481M | $441M | $318M | $317M | $307M | $252M | |
| CapEx | $219M | $233M | $319M | $325M | $229M | $167M | $141M | $140M | $82M | $55M | $63M | $57M | |
| Investing Cash Flow | $-209M | $-245M | $-563M | $-608M | $-1.44B | $-602M | $-682M | $-955M | $-73M | $-693M | · | · | |
| Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | $237M | $1.04B | · | · | |
| Net Debt Issued | $1.23B | $1.08B | $776M | $2.95B | $6.95B | $2.23B | $3.36B | $2.76B | · | · | · | · | |
| Stock Repurchased | $361M | $119M | $24M | $39M | $41M | $24M | $18M | $14M | $107M | $12M | $117M | $122M | |
| Net Stock Activity | $-361M | $-119M | $-24M | $-39M | $-41M | $-24M | $-18M | $-14M | $-107M | $-12M | $-117M | $-122M | |
| Financing Cash Flow | $-537M | $-551M | $-86M | $-42M | $673M | $47M | $232M | $558M | $-208M | $381M | · | · | |
| Net Change in Cash | $10M | $-79M | $43M | $-5M | $13M | $-7M | $43M | $31M | $46M | $-69.0K | $-43M | $4M | |
| Taxes Paid | $120M | $126M | $90M | $76M | $75M | $60M | $54M | $68M | · | · | · | · | |
| Free Cash Flow | $518M | $502M | $365M | $295M | $532M | $380M | $340M | $301M | $236M | $245M | $225M | $195M | |
| Levered FCF | · | · | $252M | $248M | $471M | $309M | $290M | $250M | $223M | $226M | $213M | $186M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.1% | 15.1% | 13.7% | |
| Net Margin | -3.6% | 0.55% | 11.5% | 12.2% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 9.2% | 10.9% | · | |
| Pretax Margin | -2.5% | 2.3% | 14.1% | 15.7% | 13.6% | 15.3% | 11.6% | 12.4% | 16.0% | 13.3% | 14.3% | 13.7% | |
| EBITDA Margin | 10.7% | 14.5% | 22.6% | 24.0% | 24.2% | 22.8% | 20.9% | 21.8% | 22.5% | 21.6% | 22.1% | 21.1% | |
| ROA | -2.0% | 0.28% | 6.0% | 6.7% | 6.2% | 7.1% | 5.9% | 6.7% | 4.4% | 6.5% | 7.6% | · | |
| ROE | -4.4% | 0.63% | 14.4% | 17.6% | 16.8% | 19.4% | 17.1% | 19.2% | 13.1% | 19.7% | 21.2% | · | |
| ROIC | 1.1% | 1.8% | 14.2% | 17.3% | 19.3% | 16.4% | 17.6% | 9.0% | 5.6% | 8.1% | 10.2% | 9.1% |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 | 1.4 | 1.4 | 1.6 | 1.8 | 1.5 | 1.8 | 2.0 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.1 | 1.2 | 1.4 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 1.1 | 1.4 | 1.1 | 1.1 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 1.2 | 1.0 | 1.4 | 1.1 | 1.1 | |
| Interest Coverage | · | · | 4.5 | 11.0 | 8.0 | 5.0 | 5.8 | 5.2 | 9.7 | 8.6 | 13.7 | 14.9 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.7 | 2.9 | 2.9 | 3.0 | |
| Receivables Turnover | 5.6 | 5.4 | 5.4 | 5.7 | 5.6 | 5.2 | 5.3 | 5.0 | 4.7 | 5.3 | 5.2 | 5.4 |
성장률 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.85% | -1.9% | 3.9% | 12.3% | 21.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.33% | 4.6% | 12.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | -97.8% | -2.7% | 24.7% | 5.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -70.3% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | -95.3% | -2.4% | 24.4% | 7.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -61.6% | 9.2% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | |
| Net Income TTM | $-144M | $22M | $475M | $486M | $391M | $364M | $252M | $226M | $123M | $155M | $149M | $127M | |
| Market Cap | $10.02B | $9.52B | $12.14B | $11.10B | $18.64B | $12.53B | $7.43B | $5.39B | $5.19B | $3.61B | $3.74B | $3.04B | |
| Enterprise Value | $9.81B | $9.33B | $11.86B | $10.87B | $18.40B | $12.34B | $7.23B | $6.84B | $6.12B | $4.70B | $4.46B | $3.64B | |
| P/E | -70.0 | 930.8 | 25.6 | 23.0 | 48.6 | 35.0 | 30.0 | 24.2 | 43.1 | 23.6 | 25.6 | 24.2 | |
| P/S | 2.5 | 2.4 | 2.9 | 2.8 | 5.3 | 4.3 | 2.8 | 2.4 | 2.8 | 2.1 | 2.7 | 2.3 | |
| P/B | 3.2 | 2.8 | 3.4 | 3.7 | 7.4 | 5.9 | 4.5 | 4.1 | 5.0 | 4.3 | 5.1 | 4.5 | |
| P / Tangible Book | 166.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 13.6 | 13.0 | 17.7 | 17.9 | 24.5 | 22.9 | 15.5 | 12.2 | 16.3 | 12.0 | 13.0 | 12.1 | |
| P / FCF | 19.3 | 19.0 | 33.2 | 37.6 | 35.0 | 33.0 | 21.8 | 17.9 | 22.0 | 14.7 | 16.6 | 15.6 | |
| EV / EBITDA | 22.9 | 15.8 | 12.7 | 11.4 | 21.5 | 18.5 | 13.2 | 13.9 | 14.6 | 12.9 | 14.8 | 13.3 | |
| EV / FCF | 18.9 | 18.6 | 32.5 | 36.9 | 34.6 | 32.5 | 21.2 | 22.7 | 26.0 | 19.2 | 19.8 | 18.6 | |
| EV / Revenue | 2.4 | 2.3 | 2.9 | 2.7 | 5.2 | 4.2 | 2.8 | 3.0 | 3.3 | 2.8 | 3.3 | 2.8 | |
| Earnings Yield | -1.4% | 0.11% | 3.9% | 4.3% | 2.1% | 2.9% | 3.3% | 4.1% | 2.3% | 4.2% | 3.9% | 4.1% |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $996M | $994M | $1.00B | $1.03B | $984M | $1.00B | $1.01B | $1.03B | $1.01B | $1.01B | $1.03B | $1.03B | $1.10B | $989M | |
| Cost of Revenue | · | · | · | · | · | · | · | $661M | $672M | $667M | · | $665M | $652M | · | · | |
| SG&A Expense | $229M | $159M | $196M | $178M | $192M | $178M | $196M | $199M | $170M | $186M | $197M | $176M | $175M | $200M | $184M | |
| Operating Income | $120M | $120M | $-283M | $134M | $100M | $75M | $-168M | $117M | $152M | $126M | $133M | $152M | $168M | $164M | $151M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $35M | · | $34M | $34M | · | $11M | |
| Interest Income | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $1M | $806.0K | $343.0K | $122.0K | |
| Other Non-op | $-37M | $-124M | $12M | $-23M | $154.0K | $-12M | $-23M | $3M | $-2M | $6M | $108M | $-6M | $-3M | $116M | $-17M | |
| Income Tax | $54M | $-15M | $-18M | $32M | $19M | $10M | $-3M | $21M | $25M | $25M | $20M | $25M | $27M | $56M | $25M | |
| Net Income | $-1M | $-15M | $-277M | $54M | $52M | $25M | $-214M | $70M | $94M | $73M | $187M | $87M | $103M | $187M | $96M | |
| EPS (Basic) | $-0.03 | $-0.30 | $-5.58 | $1.11 | $1.06 | $0.50 | $-4.20 | $1.34 | $1.75 | $1.31 | $3.65 | $1.70 | $2.02 | $3.68 | $1.90 | |
| EPS (Diluted) | $-0.03 | $-0.30 | $-5.57 | $1.10 | $1.06 | $0.50 | $-4.17 | $1.33 | $1.74 | $1.30 | $3.64 | $1.69 | $2.01 | $3.66 | $1.88 | |
| Shares (Basic) | 48,021,000 | 48,951,000 | -99,475,000 | 49,213,000 | 49,149,000 | 50,677,000 | -103,002,000 | 51,394,000 | 51,551,000 | 51,437,000 | 28,000 | 51,283,000 | 51,097,000 | -101,521,000 | 50,870,000 | |
| Shares (Diluted) | 48,021,000 | 48,951,000 | -100,031,000 | 49,426,000 | 49,316,000 | 50,853,000 | -103,643,000 | 51,583,000 | 51,846,000 | 51,842,000 | -42,000 | 51,607,000 | 51,428,000 | -102,590,000 | 51,283,000 | |
| EBITDA | $187M | $187M | · | $219M | $220M | $195M | · | $206M | $238M | $211M | · | $230M | $245M | · | $226M |
대차대조표 28
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192M | $192M | $214M | $207M | $183M | $229M | $195M | $210M | $179M | $327M | · | $157M | $202M | · | $194M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Receivables | $712M | $700M | $709M | $734M | $768M | $757M | $721M | $754M | $762M | $787M | · | $799M | $788M | · | $771M | |
| Inventory | $346M | $360M | $299M | $303M | $280M | $290M | $279M | $336M | $349M | $361M | · | $293M | $263M | · | $262M | |
| Prepaid Expense | $179M | $135M | $129M | $166M | $130M | $100M | $106M | $102M | $111M | $99M | · | $93M | $92M | · | $97M | |
| Current Assets | $1.53B | $1.49B | $1.45B | $1.53B | $1.47B | $1.51B | $1.40B | $1.49B | $1.50B | $1.67B | · | $1.44B | $1.45B | · | $1.42B | |
| PP&E (Net) | $1.49B | $1.51B | $1.66B | $1.59B | $1.61B | $1.59B | $1.60B | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | $2.96B | $2.94B | $3.19B | $3.09B | $3.10B | $3.05B | $3.06B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $1.46B | $1.43B | $1.54B | $1.50B | $1.50B | $1.46B | $1.45B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.08B | $3.04B | $2.76B | $2.92B | $2.94B | $2.87B | $2.85B | $3.12B | $3.08B | $3.07B | · | $2.88B | $2.90B | · | $2.78B | |
| Intangibles | $253M | $249M | $340M | $571M | $602M | $656M | $723M | $778M | $800M | $828M | · | $886M | $958M | · | $968M | |
| Other Non-current Assets | $588M | $826M | $293M | $291M | $296M | $294M | $278M | $307M | $301M | $303M | · | $155M | $154M | · | $430M | |
| Total Assets | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Accounts Payable | $141M | $134M | $149M | $170M | $146M | $149M | $140M | $136M | $133M | $130M | · | $136M | $120M | · | $182M | |
| Accrued Liabilities | $380M | $372M | $270M | $229M | $232M | $242M | $232M | $208M | $192M | $191M | · | $198M | $221M | · | $197M | |
| Current Liabilities | $1.13B | $1.09B | $1.12B | $1.12B | $1.08B | $1.05B | $994M | $1.01B | $948M | $955M | · | $994M | $981M | · | $1.01B | |
| Capital Leases | $408M | $393M | $434M | $443M | $454M | $475M | $484M | $433M | $429M | $418M | · | $390M | $418M | · | $369M | |
| Deferred Tax | $79M | $81M | $95M | $123M | $109M | $107M | $107M | $168M | $165M | $180M | · | $185M | $212M | · | $196M | |
| Other Non-current Liabilities | $403M | $511M | $138M | $189M | $185M | $196M | $195M | $237M | $225M | $235M | · | $173M | $187M | · | $195M | |
| Total Liabilities | $4.64B | $4.74B | $3.92B | $4.06B | $4.16B | $4.34B | $4.02B | $4.18B | $4.18B | $4.45B | · | $4.26B | $4.54B | · | $4.71B | |
| Total Debt | $5M | $7M | · | $54.0K | $98.0K | $121.0K | · | $157.0K | $435.0K | $459.0K | · | $797.0K | · | · | $0 | |
| Common Stock | $496.0K | $493.0K | $492.0K | $514.0K | $513.0K | $512.0K | $511.0K | $517.0K | $517.0K | $515.0K | · | $514.0K | $512.0K | · | $510.0K | |
| Retained Earnings | $1.37B | $1.37B | $1.39B | $1.94B | $1.89B | $1.84B | $1.81B | $2.12B | $2.05B | $1.96B | · | $1.72B | $1.54B | · | $1.28B | |
| Treasury Stock | $323M | $210M | $0 | $363M | $363M | $357M | $0 | $120M | $18M | $9M | · | $24M | $19M | · | $38M | |
| AOCI | $-196M | $-191M | $-172M | $-192M | $-166M | $-265M | $-317M | $-193M | $-270M | $-250M | · | $-268M | $-239M | · | $-396M | |
| Stockholders' Equity | $2.84B | $2.94B | $3.16B | $3.41B | $3.35B | $3.19B | $3.46B | $3.78B | $3.72B | $3.64B | · | $3.31B | $3.11B | · | $2.63B | |
| Liabilities + Equity | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B | $7.95B | $8.15B | · | $7.61B | $7.70B | · | $7.38B | |
| Shares Outstanding | 47,728,000 | 48,167,000 | 49,217,000 | 49,215,000 | 49,209,000 | 49,115,000 | 51,141,000 | 51,134,000 | 51,613,000 | 51,510,000 | · | 51,296,000 | 51,182,000 | 50,944,000 | 50,877,000 |
현금 흐름 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $78M | $85M | $120M | $120M | $102M | $88M | $86M | $85M | $81M | $79M | $77M | $78M | $75M | |
| Stock-based Comp | $20M | $22M | $18M | $23M | $17M | $13M | $17M | $19M | $17M | $17M | $20M | $23M | $13M | $22M | $22M | |
| Amort. of Intangibles | $15M | $15M | $21M | $27M | $65M | $65M | $41M | $32M | $32M | $33M | $34M | $34M | $35M | $35M | $36M | |
| Restructuring | $23M | $32M | $26M | $17M | $32M | $24M | $41M | $31M | $18M | $17M | $8M | $15M | $3M | $4M | $1M | |
| Other Non-cash | · | $-34M | · | · | · | $13M | · | · | · | $-45M | · | · | $-84M | · | · | |
| Operating Cash Flow | $180M | $41M | $148M | $214M | $205M | $172M | $159M | $252M | $194M | $130M | $221M | $205M | $109M | $235M | $133M | |
| CapEx | $31M | $56M | $89M | $36M | $35M | $59M | $76M | $39M | $39M | $79M | $78M | $66M | $107M | $89M | $72M | |
| Investing Cash Flow | $28M | $-408M | $-93M | $-34M | $-37M | $-45M | $-76M | $-21M | $-62M | $-86M | $-238M | $-80M | $-169M | $44M | $-92M | |
| Debt Issued | $353M | $912M | $157M | $107M | $547M | $416M | $105M | $236M | $440M | $301M | $443M | $51M | $192M | $154M | $618M | |
| Net Debt Issued | · | $912M | · | · | · | $416M | · | · | · | $301M | · | · | $192M | · | · | |
| Stock Repurchased | $116M | $208M | $96.0K | $93.0K | $7M | $353M | $124.0K | $101M | $9M | $9M | $139.0K | $38.0K | $19M | $159.0K | $24.0K | |
| Net Stock Activity | · | $-208M | · | · | · | $-353M | · | · | · | $-9M | · | · | $-19M | · | · | |
| Financing Cash Flow | $-165M | $348M | $-52M | $-153M | $-227M | $-105M | $-76M | $-208M | $-286M | $18M | $124M | $-163M | $25M | $-249M | $-52M | |
| Net Change in Cash | $42M | $-18M | $7M | $24M | $-47M | $26M | $-6M | $31M | $-158M | $54M | $119M | $-43M | $-32M | $45M | $-11M | |
| Taxes Paid | $16M | $2M | $27M | $19M | $57M | $17M | $31M | $23M | $53M | $19M | $15M | $14M | $14M | · | · | |
| Free Cash Flow | · | $-15M | · | · | · | $112M | · | · | · | $51M | · | · | $3M | · | · |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 12.0% | · | 13.3% | 9.7% | 7.6% | · | 11.6% | 14.8% | 12.4% | · | 14.8% | 16.3% | · | 15.3% | |
| Net Margin | -0.15% | -1.5% | · | 5.4% | 5.1% | 2.6% | · | 6.9% | 9.2% | 7.2% | · | 8.5% | 10.0% | · | 9.8% | |
| EBITDA Margin | 18.6% | 18.8% | · | 21.8% | 21.3% | 19.8% | · | 20.4% | 23.2% | 20.9% | · | 22.4% | 23.8% | · | 22.8% | |
| ROA | -0.02% | -0.19% | · | 0.70% | 0.67% | 0.32% | · | 0.89% | 1.2% | 0.92% | · | 1.2% | · | · | 1.3% | |
| ROE | -0.05% | -0.48% | · | 1.5% | 1.5% | 0.75% | · | 2.0% | 2.7% | 2.2% | · | 2.9% | · | · | 3.8% |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 1.5 | · | · | 1.4 | |
| Quick Ratio | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.2 | · | 1.0 | · | · | 1.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.6 | · | 4.5 | 4.9 | · | 13.3 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 2.1 | 2.1 | 2.1 | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | · | · | 1.4 |
가치 평가 (TTM) 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.04B | $4.02B | · | $4.03B | $4.05B | $4.03B | · | $4.07B | $4.12B | $4.13B | · | $4.11B | $3.91B | · | $3.77B | |
| Net Income TTM | $90M | $117M | · | $202M | $242M | $262M | · | $324M | $351M | $360M | · | $384M | $402M | · | $402M | |
| Market Cap | $10.30B | $7.67B | · | $7.31B | $7.38B | $7.64B | · | $10.14B | $10.66B | $13.96B | · | $10.05B | · | · | $9.54B | |
| Enterprise Value | $10.11B | $7.48B | · | $7.10B | $7.20B | $7.41B | · | $9.93B | $10.48B | $13.63B | · | $9.90B | · | · | $9.35B | |
| P/E | 117.9 | 67.4 | · | 37.2 | 32.4 | 31.9 | · | 32.7 | 31.2 | 39.3 | · | 26.2 | 25.8 | · | 23.9 | |
| P/S | 2.6 | 1.9 | · | 1.8 | 1.8 | 1.9 | · | 2.5 | 2.6 | 3.4 | · | 2.4 | · | · | 2.5 | |
| P/B | 3.6 | 2.6 | · | 2.1 | 2.2 | 2.4 | · | 2.7 | 2.9 | 3.8 | · | 3.0 | · | · | 3.6 | |
| P / Cash Flow | · | 186.6 | · | · | · | 44.5 | · | · | · | 107.5 | · | · | · | · | · | |
| P / FCF | · | -516.9 | · | · | · | 68.0 | · | · | · | 275.0 | · | · | · | · | · | |
| EV / EBITDA | 54.0 | 40.0 | · | 32.4 | 32.8 | 38.0 | · | 48.3 | 44.1 | 64.5 | · | 43.0 | · | · | 41.4 | |
| EV / FCF | · | -504.4 | · | · | · | 65.9 | · | · | · | 268.6 | · | · | · | · | · | |
| EV / Revenue | 2.5 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.4 | 2.5 | 3.3 | · | 2.4 | · | · | 2.5 | |
| Earnings Yield | 0.85% | 1.5% | · | 2.7% | 3.1% | 3.1% | · | 3.1% | 3.2% | 2.5% | · | 3.8% | 3.9% | · | 4.2% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| 매출 | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B |
| 영업이익률 % | 0.63% | 5.6% | 14.9% | 16.4% | 16.7% |
| 순이익 | $-144M | $22M | $475M | $486M | $391M |
| 희석 EPS | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 |
대차대조표
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 유동비율 | 1.3 | 1.4 | 1.5 | 1.3 | 1.2 |
| 당좌 비율 | 0.8 | 0.9 | 1.0 | 0.9 | 0.9 |
현금 흐름
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $518M | $502M | $365M | $295M | $532M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 617개의 제출자 · $7.8B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 82 (-1 이전 분기 대비) | 59 (-23 이전 분기 대비) | 180 (-11 이전 분기 대비) | 201 (+15 이전 분기 대비) | +5.0M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| FMR LLC | $737,350,307 | 3,251,247 | 9.42% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $714,227,026 | 3,149,288 | 9.12% | 주식 |
| HARRIS ASSOCIATES L P | $508,269,048 | 2,241,144 | 6.49% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $501,427,927 | 2,210,979 | 6.40% | 주식 |
| STATE STREET CORP | $422,800,968 | 1,864,284 | 5.40% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $348,883,077 | 1,538,354 | 4.46% | 주식 |
| CITADEL ADVISORS LLC | $270,696,771 | 1,193,601 | 3.46% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $259,130,041 | 1,144,937 | 3.31% | 주식 |
| EARNEST PARTNERS LLC | $254,007,295 | 1,120,011 | 3.24% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $223,361,616 | 984,883 | 2.85% | 주식 |
| AMERIPRISE FINANCIAL INC | $192,886,814 | 850,503 | 2.46% | 주식 |
| NEUBERGER BERMAN GROUP LLC | $192,182,793 | 847,488 | 2.45% | 주식 |
| Clearbridge Investments, LLC | $177,185,527 | 781,276 | 2.26% | 주식 |
| COOKE & BIELER LP | $171,369,328 | 755,630 | 2.19% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $150,762,735 | 664,768 | 1.93% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $110,324,717 | 486,462 | 1.41% | 주식 |
| BANK OF AMERICA CORP /DE/ | $104,921,899 | 462,639 | 1.34% | 주식 |
| Gotham Asset Management, LLC | $98,233,181 | 433,146 | 1.25% | 주식 |
| Amundi | $93,528,650 | 412,402 | 1.19% | 주식 |
| NORGES BANK | $83,921,372 | 370,040 | 1.07% | 주식 |
| MARSHALL WACE, LLP | $76,947,125 | 339,288 | 0.98% | 주식 |
| Iron Triangle Partners LP | $75,748,141 | 379,728 | 0.97% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $64,615,913 | 374,585 | 0.83% | 주식 |
| SNYDER CAPITAL MANAGEMENT L P | $63,899,443 | 281,756 | 0.82% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $63,174,169 | 278,558 | 0.81% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $63,095,473 | 278,211 | 0.81% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $61,384,115 | 270,665 | 0.78% | 주식 |
| PRIMECAP MANAGEMENT CO/CA/ | $60,523,448 | 266,870 | 0.77% | 주식 |
| GOLDMAN SACHS GROUP INC | $57,319,812 | 252,744 | 0.73% | 주식 |
| Meridiem Capital Partners LP | $56,012,367 | 246,979 | 0.72% | 주식 |
| Alyeska Investment Group, L.P. | $53,295,650 | 235,000 | 0.68% | 주식 |
| Quantinno Capital Management LP | $49,020,824 | 216,150 | 0.63% | 주식 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $48,415,129 | 213,480 | 0.62% | 주식 |
| Boston Trust Walden Corp | $46,506,918 | 205,066 | 0.59% | 주식 |
| Burgundy Asset Management Ltd. | $45,453,909 | 278,329 | 0.58% | 주식 |
| SRS Investment Management, LLC | $42,496,817 | 187,384 | 0.54% | 주식 |
| LOOMIS SAYLES & CO L P | $38,517,487 | 169,838 | 0.49% | 주식 |
| JONES FINANCIAL COMPANIES LLLP | $37,184,513 | 172,350 | 0.47% | 주식 |
| PERCEPTIVE ADVISORS LLC | $31,750,600 | 140,000 | 0.41% | 주식 |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $30,389,860 | 134,000 | 0.39% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $29,879,583 | 131,750 | 0.38% | 주식 |
| BlackRock, Inc. | $29,025,945 | 127,986 | 0.37% | 주식 |
| PICTON MAHONEY ASSET MANAGEMENT | $26,340,305 | 116,144 | 0.34% | 주식 |
| FIL Ltd | $25,184,576 | 111,048 | 0.32% | 주식 |
| Candriam S.C.A. | $23,824,478 | 105,152 | 0.30% | 주식 |
| Clark Capital Management Group, Inc. | $23,010,567 | 101,462 | 0.29% | 주식 |
| Vanguard Global Advisers, LLC | $22,453,344 | 99,005 | 0.29% | 주식 |
| Swiss National Bank | $22,452,210 | 99,000 | 0.29% | 주식 |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | $20,491,384 | 90,354 | 0.26% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $20,280,546 | 89,424 | 0.26% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19,730,730 | 87,000 | 0.25% | 콜 옵션 |
| NOMURA HOLDINGS INC | $19,672,672 | 86,744 | 0.25% | 주식 |
| RHUMBLINE ADVISERS | $19,484,825 | 85,916 | 0.25% | 주식 |
| Ilex Capital Partners (UK) LLP | $18,413,760 | 81,193 | 0.24% | 주식 |
| Aristotle Capital Boston, LLC | $18,273,438 | 80,574 | 0.23% | 주식 |
| CITADEL ADVISORS LLC | $17,485,509 | 77,100 | 0.22% | 콜 옵션 |
| NICHOLAS COMPANY, INC. | $16,305,067 | 71,895 | 0.21% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $15,172,024 | 66,899 | 0.19% | 주식 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $15,164,087 | 66,864 | 0.19% | 주식 |
| Ranger Investment Management, L.P. | $15,009,416 | 66,182 | 0.19% | 주식 |
| California Public Employees Retirement System | $14,670,818 | 64,689 | 0.19% | 주식 |
| Assenagon Asset Management S.A. | $14,020,385 | 61,821 | 0.18% | 주식 |
| ASSETMARK, INC | $13,939,194 | 61,463 | 0.18% | 주식 |
| Rhenman & Partners Asset Management AB | $12,972,388 | 57,200 | 0.17% | 주식 |
| RIVERBRIDGE PARTNERS LLC | $12,859,587 | 56,703 | 0.16% | 주식 |
| TD Asset Management Inc | $12,854,230 | 56,679 | 0.16% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $12,836,314 | 56,600 | 0.16% | 풋 옵션 |
| Laurus Investment Counsel Inc. | $12,365,663 | 71,685 | 0.16% | 주식 |
| KING LUTHER CAPITAL MANAGEMENT CORP | $12,204,023 | 53,812 | 0.16% | 주식 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $11,552,133 | 50,938 | 0.15% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10,732,081 | 47,278 | 0.14% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $10,506,727 | 46,328 | 0.13% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $10,472,482 | 46,177 | 0.13% | 주식 |
| KENNEDY CAPITAL MANAGEMENT LLC | $9,914,950 | 43,719 | 0.13% | 주식 |
| BARCLAYS PLC | $9,909,816 | 43,696 | 0.13% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9,827,670 | 56,972 | 0.13% | 주식 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $9,382,529 | 41,371 | 0.12% | 주식 |
| Park West Asset Management LLC | $9,343,748 | 41,200 | 0.12% | 주식 |
| State of Tennessee, Department of Treasury | $8,457,000 | 37,290 | 0.11% | 주식 |
| J.P. Marvel Investment Advisors, LLC | $8,456,092 | 37,286 | 0.11% | 주식 |
| CASTLEARK MANAGEMENT LLC | $8,174,646 | 36,045 | 0.10% | 주식 |
| JANE STREET GROUP, LLC | $7,869,613 | 34,700 | 0.10% | 콜 옵션 |
| Pine Ridge Advisers LLC | $7,710,860 | 34,000 | 0.10% | 주식 |
| PRUDENTIAL FINANCIAL INC | $7,346,635 | 32,394 | 0.09% | 주식 |
| Capricorn Fund Managers Ltd | $7,092,630 | 31,274 | 0.09% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $7,000,554 | 30,868 | 0.09% | 주식 |
| FIRST TRUST ADVISORS LP | $6,951,290 | 30,651 | 0.09% | 주식 |
| Caption Management, LLC | $6,803,700 | 30,000 | 0.09% | 풋 옵션 |
| Engineers Gate Manager LP | $6,637,463 | 29,267 | 0.08% | 주식 |
| LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE | $6,351,027 | 28,004 | 0.08% | 주식 |
| Midwest Trust Co | $6,091,126 | 26,858 | 0.08% | 주식 |
| VAN ECK ASSOCIATES CORP | $5,942,578 | 26,203 | 0.08% | 주식 |
| SEI INVESTMENTS CO | $5,929,630 | 26,150 | 0.08% | 주식 |
| Sendero Wealth Management, LLC | $5,909,468 | 26,057 | 0.08% | 주식 |
| 13D Management LLC | $5,851,182 | 25,800 | 0.07% | 주식 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $5,500,853 | 31,889 | 0.07% | 주식 |
| D. E. Shaw & Co., Inc. | $5,462,691 | 24,087 | 0.07% | 주식 |
| INVESTMENT HOUSE LLC | $5,447,042 | 24,018 | 0.07% | 주식 |
| LPL Financial LLC | $5,409,169 | 23,851 | 0.07% | 주식 |
| LRT Capital Management, LLC | $5,348,842 | 23,585 | 0.07% | 주식 |
회사 내부자 57 명의 내부자 · 21 임원 · 27 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Glenn Coleman | EVP & Chief Financial Officer | 2026년 5월 29일 A | 27,752 | 0 | 0 | $0 |
| Flavia Pease | Corporate Executive VP & CFO | 2025년 5월 31일 F | 17,297 | 0 | 0 | $0 |
| David Ross Smith | Corporate Executive VP & CFO | 2022년 3월 3일 M | 25,819 | 0 | 0 | $0 |
| Davide Molho | President & COO | 2018년 7월 24일 M | 17,155 | 0 | 0 | $0 |
| Mark Mintz | EVP, Chief Information Officer | 2026년 5월 31일 F | 9,546 | 0 | 0 | $0 |
| William D Barbo | Corporate Executive VP & CCO | 2024년 11월 7일 G | 23,337 | 0 | 0 | $0 |
| John W Kuo | CEVP General Counsel & CCO | 2020년 6월 1일 A | 3,171 | 0 | 0 | $0 |
| David P Johst | Corporate Executive VP | 2020년 5월 29일 A | 224,478 | 0 | 0 | $0 |
| John J Crowley | SVP, Chief Accounting Officer | 2016년 10월 1일 F | 5,599 | 0 | 0 | $0 |
| Nancy Gillett | Corporate Executive VP | 2016년 3월 2일 S | 11,034 | 0 | 0 | $0 |
| Jorg Geller | Corporate Executive VP | 2015년 2월 25일 M | 14,094 | 0 | 0 | $0 |
| RENAUD REAL H | Corp. Executive VP | 2010년 8월 11일 F | 74,390 | 0 | 0 | $0 |
| Christopher Berthoux | Executive Vice President | 2010년 2월 26일 A | 31,897 | 0 | 0 | $0 |
| Joanne P Acford | Corp. Sr VP, GC and Corp. Sec | 2007년 8월 11일 F | 37,109 | 0 | 0 | $0 |
| David J Elliott | Officer | 2007년 6월 29일 M | 11,750 | 0 | 0 | $0 |
| Cheri L Walker | Corporate Senior VP | 2007년 5월 1일 A | 6,262 | 0 | 0 | $0 |
| Stephanie B Wells | Senior Vice President | 2007년 4월 2일 A | 11,500 | 0 | 0 | $0 |
| Nicholas Ventresca | Senior Vice President | 2007년 4월 2일 F | 12,713 | 0 | 0 | $0 |
| John C Ho | Senior Vice President | 2007년 2월 23일 A | 12,710 | 0 | 0 | $0 |
| Brian Bathgate | Corporate Vice President | 2006년 2월 27일 S | 16,134 | 0 | 0 | $0 |
| Alastair Stuart Mcewan | Corporate VP | 2004년 12월 23일 M | 8,000 | 0 | 0 | $0 |
| Steven Barg | 이사 | 2026년 6월 2일 A | 3,287 | 0 | 0 | $0 |
| Nancy C Andrews | 이사 | 2026년 5월 12일 G | 3,964 | 0 | 0 | $0 |
| Reshema Kemps-Polanco | 이사 | 2026년 5월 8일 A | 4,563 | 0 | 0 | $0 |
| George Llado | 이사 | 2026년 5월 8일 A | 6,702 | 0 | 0 | $0 |
| Abraham Ceesay | 이사 | 2026년 5월 8일 A | 2,384 | 0 | 0 | $0 |
| Mark J Enyedy | 이사 | 2026년 5월 8일 A | 2,384 | 0 | 0 | $0 |
| Paul W Graves | 이사 | 2026년 5월 8일 A | 2,384 | 0 | 0 | $0 |
| Craig B. Thompson | 이사 | 2026년 5월 8일 A | 3,851 | 0 | 0 | $0 |
| Martin Mackay | 이사 | 2026년 5월 8일 A | 17,137 | 0 | 0 | $0 |
| Virginia M Wilson | 이사 | 2026년 5월 8일 A | 6,349 | 0 | 0 | $0 |
| George Massaro | 이사 | 2025년 5월 15일 S | 5,575 | 0 | 0 | $0 |
| Richard F Wallman | 이사 | 2024년 11월 7일 S | 0 | 0 | 0 | $0 |
| Deborah Turner Kochevar | 이사 | 2024년 5월 13일 A | 7,894 | 0 | 0 | $0 |
| Robert J Bertolini | 이사 | 2024년 5월 13일 A | 32,802 | 0 | 0 | $0 |
| Richard C Reese | 이사 | 2023년 5월 15일 A | 65,541 | 0 | 0 | $0 |
| George M Milne JR | 이사 | 2021년 5월 7일 A | 29,079 | 0 | 0 | $0 |
| Stephen D Chubb | 이사 | 2021년 2월 23일 M | 40,529 | 0 | 0 | $0 |
| Jean-Paul Mangeolle | 이사 | 2019년 5월 22일 A | 3,886 | 0 | 0 | $0 |
| William Waltrip | 이사 | 2012년 12월 5일 S | 21,830 | 0 | 0 | $0 |
| Samuel O Thier MD | 이사 | 2012년 5월 9일 A | 18,230 | 0 | 0 | $0 |
| Douglas E Rogers | 이사 | 2010년 5월 7일 A | 12,859 | 0 | 0 | $0 |
| Nancy T Chang | 이사 | 2010년 5월 7일 A | 31,010 | 0 | 0 | $0 |
| Linda Mcgoldrick | 이사 | 2006년 2월 13일 A | — | 0 | 0 | $0 |
| Walter S Nimmo | 이사 | 2005년 2월 25일 S | 149,447 | 0 | 0 | $0 |
| John Urquhart | 이사 | 2005년 2월 17일 A | 11,738 | 0 | 0 | $0 |
| Louise S Mccrary | 이사 | 2005년 2월 17일 A | — | 0 | 0 | $0 |
| Robert Cawthorn | 이사 | 2004년 6월 2일 G | 278,600 | 0 | 0 | $0 |
| Shannon M Parisotto | — | 2026년 8월 11일 M | 4,807 | 0 | 2 | $-2,365,755 |
| Birgit Girshick | — | 2026년 8월 11일 M | 36,013 | 0 | 1 | $-1,819,350 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 6 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| JANA PARTNERS LLC ×4 제출 서류 | 2011년 8월 4일 | — | 최초 제출 | — | SEC |
| Relational Investors, LLC, Relational Investors Mid-Cap Fund I, L.P., Relational Investors Mid-Cap Fund II, L.P., Ralph V. Whitworth, David H. Batchelder, California State Teachers’ Retirement System ×3 제출 서류 | 2011년 2월 9일 | — | 최초 제출 | — | SEC |
| Neuberger Berman Group LLC, Neuberger Berman LLC, Neuberger Berman Management ×3 제출 서류 | 2010년 12월 7일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2010년 6월 16일 | — | 최초 제출 | — | SEC |
| 미공개 보고자 | 2010년 6월 7일 | — | 최초 제출 | 수동적 투자 | SEC |
| Charles River Laboratories International, Inc. IRS No. 061397316 | 2010년 5월 5일 | — | 최초 제출 | 이사회 캠페인 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 135 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 2.18% | 63,652 SH | 2026년 8월 8일 | 일간 |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.49% | 4,749 NS | 2026년 4월 30일 | N-PORT |
| EPSB · Harbor ETF Trust | 1.33% | 370 NS | 2026년 4월 30일 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 1.18% | 41,597 SH | 2026년 8월 8일 | 일간 |
| EPMV · Harbor ETF Trust | 1.09% | 291 NS | 2026년 4월 30일 | N-PORT |
| IBB · iShares Trust | 0.97% | 349,491 SH | 2026년 8월 8일 | 일간 |
| EPSV · Harbor ETF Trust | 0.90% | 270 NS | 2026년 4월 30일 | N-PORT |
| TAX · EA Series Trust | 0.80% | 1,131 NS | 2026년 5월 29일 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.66% | 612 NS | 2026년 4월 30일 | N-PORT |
| HIBL · Direxion Shares ETF Trust | 0.50% | 2,356 NS | 2026년 4월 30일 | N-PORT |
| ISCV · iShares Trust | 0.40% | 10,497 SH | 2026년 8월 8일 | 일간 |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.38% | 11,925 NS | 2026년 4월 30일 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.38% | 25,401 SH | 2026년 8월 8일 | 일간 |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0.36% | 1,145,000 PA | 2026년 8월 8일 | 일간 |
| IQSM · New York Life Investments ETF Trust | 0.33% | 6,161 NS | 2026년 4월 30일 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.29% | 22,440 NS | 2026년 4월 30일 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.27% | 996,151 SH | 2026년 8월 8일 | 일간 |
| DFAT · Dimensional ETF Trust | 0.26% | 212,321 NS | 2026년 4월 30일 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.23% | 701,498 SH | 2026년 8월 8일 | 일간 |
| ESML · iShares Trust | 0.23% | 24,979 SH | 2026년 8월 8일 | 일간 |
| BKMC · BNY Mellon ETF Trust | 0.22% | 8,115 NS | 2026년 4월 30일 | N-PORT |
| IYH · iShares Trust | 0.21% | 29,370 SH | 2026년 8월 8일 | 일간 |
| ISCB · iShares Trust | 0.20% | 2,125 SH | 2026년 8월 8일 | 일간 |
| SMMD · iShares Trust | 0.17% | 24,455 SH | 2026년 8월 8일 | 일간 |
| FSMD · FIDELITY COVINGTON TRUST | 0.17% | 24,528 NS | 2026년 4월 30일 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.17% | 133,341 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.16% | 138,243 NS | 2026년 4월 30일 | N-PORT |
| IXJ · iShares Trust | 0.16% | 25,598 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.16% | 148,331 SH | 2026년 8월 8일 | 일간 |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 18,369 NS | 2026년 4월 30일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.15% | 6,079 NS | 2026년 5월 31일 | N-PORT |
| WSML · iShares Trust | 0.13% | 6,018 SH | 2026년 8월 8일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 22,674 NS | 2026년 4월 30일 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.13% | 59,338 NS | 2026년 4월 30일 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.13% | 1,102,914 SH | 2026년 8월 8일 | 일간 |
| VGMS · VANGUARD MALVERN FUNDS | 0.13% | 315,000 PA | 2026년 8월 8일 | 일간 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.13% | 4,072 SH | 2026년 8월 8일 | 일간 |
| RXL · ProShares Trust | 0.13% | 513 NS | 2026년 5월 31일 | N-PORT |
| IWS · iShares Trust | 0.13% | 74,284 SH | 2026년 8월 8일 | 일간 |
| REVS · Columbia ETF Trust I | 0.12% | 2,082 NS | 2026년 4월 30일 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.12% | 982 NS | 2026년 4월 30일 | N-PORT |
| SMLF · iShares Trust | 0.12% | 18,532 SH | 2026년 8월 8일 | 일간 |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.11% | 3,280 NS | 2026년 4월 30일 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0.11% | 1,032 NS | 2026년 4월 30일 | N-PORT |
| IWR · iShares Trust | 0.09% | 199,595 SH | 2026년 8월 8일 | 일간 |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.09% | 1,986 NS | 2026년 5월 31일 | N-PORT |
| IEUS · iShares Trust | 0.09% | 4,951 SH | 2026년 8월 8일 | 일간 |
| XOEF · iShares Trust | 0.07% | 61 SH | 2026년 8월 8일 | 일간 |
| VSDB · VANGUARD MALVERN FUNDS | 0.07% | 635,000 PA | 2026년 8월 8일 | 일간 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.07% | 5,261 NS | 2026년 4월 30일 | N-PORT |